Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients
Abstract
BACKGROUND: Occult hepatitis B virus (HBV) infection frequently occurs in patients with HBV surface antigen (HBsAg)‐negative chronic liver disease, and much evidence suggests that it is a risk factor for hepatocellular carcinoma (HCC) development. However, to the authors' knowledge, no follow‐up study has been performed to date evaluating HCC occurrence over time in chronic hepatitis patients with or without occult HBV infection.METHODS: A cohort of the 380 HBsAg‐negative chronic hepatitis patients attending the study institution between 1991–2000 were evaluated and tested for occult HBV DNA by analysis of liver biopsy specimens.RESULTS: There were 135 patients (35.5%) with occult HBV and 245 patients (64.5%) without occult HBV. Cirrhosis was significantly associated with occult HBV infection (P = 0.01). One hundred thirty‐four of these patients were followed for a minimum of 50 months (median, 82.8 ± 32.6 mos). Fifty‐three patients (39%) were occult HBV carriers and 81 (61%) were not. Nine patients developed HCC during the follow‐up; eight were positive and one was negative for occult HBV (P = 0.002).CONCLUSIONS: The current observational cohort study showed that, among the HBsAg‐negative patients with chronic hepatitis, HCC develops for the most part in carriers of occult HBV. Therefore, the evaluation of HBV genomes in chronic hepatitis patients appears to be a powerful tool for the identification of individuals at higher risk of HCC development. Cancer 2006. © 2006 American Cancer Society.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (AIRC)
- Italian Ministero dell'Istruzione
- Universita e Ricerca (MIUR)
- Fondi per gli Investimenti per la Ricerca di Base (FIRB)
- Schering-Plough
This publication has 27 references indexed in Scilit:
- Occult hepatitis B virus infection in a North American community-based populationJournal of Hepatology, 2005
- What is the clinical impact of occult hepatitis B virus infection?The Lancet, 2005
- Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infectionGastroenterology, 2004
- Introduction to therapy of hepatitis CHepatology, 2002
- Occult hepatitis B virus infectionDigestive and Liver Disease, 2000
- Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infectionHepatology, 2000
- Possible Contribution to Hepatocarcinogenesis of X Transcript of Hepatitis B Virus in Japanese Patients With Hepatitis C VirusHepatology, 1999
- Towards global control of liver cancer?Seminars in Cancer Biology, 1998
- Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis BDigestive Diseases and Sciences, 1995
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular CarcinomaNew England Journal of Medicine, 1981